Two ways of epigenetic silencing of TFPI2 in cervical cancer.
Alexandra FullárKatalin KarasziPéter HollósiGábor LendvaiLászlóné OláhAndrea ReszegiZoltán PappGábor SobelJózsef DudásIlona KovalszkyPublished in: PloS one (2020)
These results indicate dual epigenetic inhibition of TFPI2 on the transcription level by promoter methylation in cancer cells and on the translation level by miR-23a in tumor-associated fibroblasts. As a consequence, inactivation of the TFPI2 gene plays a strategic role in the progression of cervical cancer.